Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summaryMarketScreener Strategies
OFFRE
MarketScreener Strategies on NOVARTIS 
NOVARTIS - 09/03
Technically solid
BUY
NOVARTIS - 04/30
Underpinned by a support level
BUY
NOVARTIS AG - 2016
A trend reversal can be anticipated
BUY
Financials ($)
Sales 2018 52 459 M
EBIT 2018 12 888 M
Net income 2018 11 683 M
Debt 2018 14 565 M
Yield 2018 3,46%
P/E ratio 2018 14,72
P/E ratio 2019 20,91
EV / Sales 2018 4,40x
EV / Sales 2019 4,24x
Capitalization 216 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart NOVARTIS
Duration : Period : Day
Novartis Technical Analysis Chart | MarketScreener
Duration : Period : Week
Novartis Technical Analysis Chart | MarketScreener